It is a chemicals and materials private limited company based in Hyderabad, Telangana, India, established in 2013.
2013 | Hyderabad, Telangana, India | Under Process Of Striking OffBiozen Drugs Private Limited, a under process of striking off private limited company, was established on 16 May 2013 in Hyderabad, Telangana, India. Engaging in specialty chemicals within the chemicals and materials sector, it holds CIN: U24232TG2013PTC087681. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Arithoti Raghurama Naidu (Additional Director), Mandati Kavitha (Additional Director). Past directors included Kanapuri Harshitha, Alla Bhaskara Reddy, Pavithra Alla. Its latest AGM occurred on 30 September 2017, with the balance sheet filed on 31 March 2017. It is based at 1-98/9/31, Flat No.101, Ramkuteer,Opposite Lane To Chocolate Room, Jaihind Enclave, Ayyappa, Society, Hyderabad, Telangana, 500085.
U24232TG2013PTC087681
087681
16 May 2013
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Under Process Of Striking Off
Explore comprehensive insights into Biozen Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arithoti Raghurama Naidu | Additional Director | 01 Oct 2017 | Current |
| Mandati Kavitha | Additional Director | 01 Oct 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Oct 2017 | Past |
| Pramod Abcsdd | Director | 14 Sep 2017 | Past |
| Pramod Abcsdd | Director | 14 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 04 Oct 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Biozen Drugs Private Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 382.45% increase. The company also saw a substantial improvement in profitability, with a 385.1% increase in profit. The company's net worth Soared by an impressive increase of 48.35%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Biozen Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Biozen Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Biozen Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biozen Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Arithoti Raghurama Naidu was appointed as a Additional Director was appointed as a Additional Director on 01 Oct 2017 & has been associated with this company since 8 years 2 months . was documented.
Progress on Mandati Kavitha was appointed as a Additional Director was appointed as a Additional Director on 01 Oct 2017 & has been associated with this company since 8 years 2 months . was documented.
The activity Biozen Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records. was completed.
The activity Biozen Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Hyderabad. was completed.
The activity Biozen Drugs Private Limited was registered on 16 May 2013 with Roc Hyderabad & aged 12 years 6 months as per MCA records. was completed.
The CIN of Biozen Drugs Private Limited is U24232TG2013PTC087681.
Biozen Drugs Private Limited is headquartered at 1-98/9/31, Flat No.101, Ramkuteer,Opposite Lane To Chocolate Room, Jaihind Enclave, Ayyappa, Society, Hyderabad, Telangana, 500085.
Biozen Drugs Private Limited was incorporated on 16 May 2013.
The current directors of Biozen Drugs Private Limited are
The primary industry of Biozen Drugs Private Limited is Chemicals And Materials.
Biozen Drugs Private Limited is unlisted.
The authorized capital of Biozen Drugs Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Biozen Drugs Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX